Among children hospitalized with CM or severe malarial anemia (SMA) with neurologic injury and higher plasma tau levels suggest that plasma tau could be a reliable biomarker for identifying children at risk of persistent neurocognitive impairment (NCI), potentially aiding in acute cognitive rehabilitation (Datta et al., 2021). Here, MAPT is linked to cutaneous mastocytosis.